Home - Yahoo! - Help

More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Reports

Recent Events July 31 Conference call: Alpharma Earnings (Q2 2001) July 27 Dividend payment of $0.045 Location One Executive Drive Fort Lee, NJ 07024 Phone: (201) 947-7774 Fax: (201) 947-4879 Employees (last reported count): 3,500 Financial Links  ·Top Institutional Holders  ·Top Mutual Fund Holders  ·Analyst Upgrade/Downgrade History  ·Historical Quote Data  ·Free Annual Report  ·Raw SEC Filings at sec.gov Competitors:  ·Sector: Healthcare  ·Industry: Biotechnology & Drugs Company Website  ·Home Page  ·Search Yahoo! for related links... Index Membership  ·S&P 600 SmallCap Ownership · Insider and 5%+ Owners: 48% · Institutional: 85% (163% of float) (417 institutions) · Net Inst. Buying: 361.0K shares (+1.04%) (prior quarter to latest quarter) More From Market Guide  ·Highlights  ·Performance  ·Ratio Comparisons

Financial Summary ALPHARMA, Inc. is a multinational pharmaceutical company which develops, manufactures and markets specialty generic and proprietary human pharmaceutical and animal health products. For the six months ended 6/30/01, revenues rose 14% to $466 million. Net income rose 16% to $22.5 million. Results reflect the acquisition of Roche Medication Feed Additive, lower interest expense and $2.1 million in income related to the settlement of the vitamin antitrust litigation. More from Market Guide: Significant Developments Officers [Insider Trade Data] FY2000 Compensation Pay Exer Einar Sissener, 72 Chairman --   --   Ingrid Wiik, 56 Pres, CEO, Director $1.1M $839K Jeffrey Smith, 53 VP-Fin. and CFO 598K 1.4M Richard Cella, 49 VP, CIO --   --   Albert Marchio II, 48 VP and Treasurer --   --   Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. More from Market Guide on Officers & Directors: Expanded List, Bios, Compensation, Options

Price and Volume 52-Week Low on 20-Apr-2001 $18.00  Recent Price $31.40  52-Week High on 17-Oct-2000 $67.875 Beta -0.01  Daily Volume (3-month avg) 362.4K Daily Volume (10-day avg) 409.0K Stock Performance big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max] 52-Week Change -42.1% 52-Week Change relative to S&P500 -22.3% Share-Related Items Market Capitalization $1.27B Shares Outstanding 40.3M Float 21.0M Dividends & Splits Annual Dividend (indicated) $0.18  Dividend Yield 0.57% Last Split none	Per-Share Data Book Value (mrq) $20.83  Earnings (ttm) $1.51  Earnings (mrq) $0.28  Sales (ttm) $19.76  Cash (mrq) $0.51  Valuation Ratios Price/Book (mrq) 1.51  Price/Earnings (ttm) 20.81  Price/Sales (ttm) 1.59  Income Statements Sales (ttm) $975.4M EBITDA (ttm) $194.2M Income available to common (ttm) $64.2M Profitability Profit Margin (ttm) 6.6% Operating Margin (ttm) 12.9% Fiscal Year Fiscal Year Ends Dec 31 Most recent quarter 30-June-2001	Management Effectiveness Return on Assets (ttm) 4.08% Return on Equity (ttm) 8.23% Financial Strength Current Ratio (mrq) 3.04  Debt/Equity (mrq) 0.62  Total Cash (mrq) $20.7M Short Interest As of 8-Aug-2001 Shares Short 6.97M Percent of Float 33.2% Shares Short (Prior Month) 6.58M Short Ratio 16.44  Daily Volume 424.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.